ZNF765 Inhibitors
Chemical inhibitors of ZNF765 operate through different molecular pathways to prevent the phosphorylation and subsequent activity of this protein. Chelerythrine and GF109203X are examples that target protein kinase C (PKC). PKC is a key enzyme in phosphorylating serine and threonine residues on various proteins. By inhibiting PKC, both chelerythrine and GF109203X interfere with the normal phosphorylation process of ZNF765, preventing it from exerting its usual function within the cell. Another inhibitor, LY294002, takes a different approach by blocking phosphoinositide 3-kinases (PI3K). Since PI3K is an upstream regulator in the AKT signaling pathway, its inhibition by LY294002 also results in a decrease in ZNF765 activity due to reduced phosphorylation. A similar effect is achieved by wortmannin, which is another potent and irreversible inhibitor of PI3K, ensuring that the downstream effects on ZNF765 are mitigated.
Beyond these, PD98059 and U0126 specifically inhibit mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway, a different signaling cascade that also contributes to the phosphorylation of proteins such as ZNF765. By blocking MEK, PD98059 and U0126 effectively reduce the phosphorylation and activity of ZNF765. In a parallel pathway, SB203580 acts on p38 MAP kinase, and by doing so, it also decreases the phosphorylation status of ZNF765. The c-Jun N-terminal kinase (JNK) pathway, which influences several cellular processes through protein phosphorylation, is targeted by SP600125, resulting in diminished phosphorylation of ZNF765. Y-27632, as a selective inhibitor of Rho-associated protein kinase (ROCK), contributes to the reduction in phosphorylation of ZNF765 by affecting the ROCK pathway. Src family tyrosine kinases, known to regulate various signaling pathways, are inhibited by PP2, which in turn reduces the phosphorylation levels of ZNF765. Lastly, SL0101 and Bisindolylmaleimide I inhibit ribosomal S6 kinase (RSK) and PKC respectively, both of which are key players in the phosphorylation and regulation of protein activities, including that of ZNF765.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
Chelerythrine is a selective inhibitor of protein kinase C (PKC), which is known to phosphorylate a variety of proteins. By inhibiting PKC, this compound can prevent the phosphorylation of ZNF765, thereby inhibiting its activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a phosphoinositide 3-kinases (PI3K) inhibitor. PI3K is upstream in the AKT signaling pathway that can lead to the activation of various proteins. Inhibition of PI3K can thus prevent the activation of AKT and subsequent phosphorylation of proteins including ZNF765. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a specific inhibitor of mitogen-activated protein kinase kinase (MEK), which is a part of the MAPK/ERK pathway. By inhibiting MEK, this chemical can prevent the activation of ERK and subsequent phosphorylation of ZNF765. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is an inhibitor of p38 MAP kinase. The p38 MAP kinase pathway is involved in the phosphorylation of various proteins. Inhibition of p38 MAP kinase can lead to reduced phosphorylation and activity of ZNF765. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a selective inhibitor of both MEK1 and MEK2. MEK1/2 are critical enzymes in the MAPK/ERK pathway, which is involved in the phosphorylation of many proteins. U0126 can inhibit the activity of ZNF765 by preventing its phosphorylation through this pathway. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K. By blocking PI3K, this compound can inhibit the phosphorylation and activation of downstream proteins such as AKT, ultimately leading to the functional inhibition of ZNF765. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). JNK is involved in the signaling pathways that regulate protein activities through phosphorylation. Inhibiting JNK can reduce the phosphorylation and activity of ZNF765. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of the Rho-associated protein kinase (ROCK). ROCK is implicated in a variety of cellular functions, including phosphorylation of proteins. By inhibiting ROCK, Y-27632 can prevent the phosphorylation of ZNF765, leading to its inhibition. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a selective inhibitor of Src family tyrosine kinases. The Src family is involved in various signaling pathways, including those regulating protein phosphorylation. PP2 can inhibit the activity of ZNF765 by preventing its phosphorylation through Src-related pathways. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
GF109203X is a potent inhibitor of protein kinase C (PKC) isoforms. By inhibiting PKC, this compound can prevent the phosphorylation of proteins, including ZNF765, thus inhibiting its function. | ||||||